Your browser doesn't support javascript.
loading
US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer.
Royce, Melanie; Mulkey, Flora; Osgood, Christy; Bloomquist, Erik; Amiri-Kordestani, Laleh.
Afiliação
  • Royce M; Melanie Royce, MD, PhD, Flora Mulkey, MS, Christy Osgood, MD, Erik Bloomquist, PhD, and Laleh Amiri-Kordestani, MD, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Mulkey F; Melanie Royce, MD, PhD, Flora Mulkey, MS, Christy Osgood, MD, Erik Bloomquist, PhD, and Laleh Amiri-Kordestani, MD, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Osgood C; Melanie Royce, MD, PhD, Flora Mulkey, MS, Christy Osgood, MD, Erik Bloomquist, PhD, and Laleh Amiri-Kordestani, MD, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Bloomquist E; Melanie Royce, MD, PhD, Flora Mulkey, MS, Christy Osgood, MD, Erik Bloomquist, PhD, and Laleh Amiri-Kordestani, MD, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Amiri-Kordestani L; Melanie Royce, MD, PhD, Flora Mulkey, MS, Christy Osgood, MD, Erik Bloomquist, PhD, and Laleh Amiri-Kordestani, MD, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
J Clin Oncol ; 41(18): 3456-3457, 2023 06 20.
Article em En | MEDLINE | ID: mdl-37104738

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2023 Tipo de documento: Article